https://www.selleckchem.com/Proteasome.html
guide surgical management. To identify modifying genes that explains the risk of fragile X-associated primary ovarian insufficiency (FXPOI). Gene-based, case/control association study, followed by a functional screen of highly ranked genes using a Drosophila model. Participants were recruited from academic and clinical settings. Women with a premutation (PM) who experienced FXPOI at the age of 35 years or younger (n = 63) and women with a PM who experienced menopause at the age of 50 years or older (n = 51) provided clinical information and a
Like
Comment
Share
